08:34 AM EST, 03/07/2024 (MT Newswires) -- Stephen Mayo, Director, on March 05, 2024, sold 3,135 shares in Sarepta Therapeutics ( SRPT ) for $385,480. Following the Form 4 filing with the SEC, Mayo has control over a total of 6,621 shares of the company, with 6,621 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/873303/000095017024027497/xslF345X03/ownership.xml

Price: 124.24, Change: +3.93, Percent Change: +3.27